The experimental anticancer therapy CR-001 was generally well tolerated in a first-in-human clinical trial that tested several doses in 11 people with acute myeloid leukemia…

Maintenance therapy for myeloma can be stopped after two years without raising the risk of disease progression or death, a new study shows. “For…

On some afternoons, while my mum and I are at the hospital, I notice how long it takes just to wait for our turn. Whether…